Patent intelligence · US
US 10870632
Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts
Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts
Patent details — US 10870632
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 22, 2020
- Expiration
- Dec 17, 2040
- Applicant
- BIONORICA ETHICS GMBH
- Claims
- 25
- CPC classes
- A61K, A61K31/35, A61K36/185, A61P
Quick answer
US 10870632 (Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts) is held by BIONORICA ETHICS GMBH. Status: granted. Granted Dec 22, 2020. Expires Dec 17, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIONORICA ETHICS GMBH
- Grant date
- Expiration
- Claims
- 25
- CPC classes
- A61K, A61K31/35, A61K36/185, A61P, A61P25/26
More from BIONORICA ETHICS GMBH
Related pharmaceutical patents in our USPTO index.
-
US 12312339
Polo like kinase 4 inhibitors
granted -
US 12239729
TRPV3 agonists for the treatment of skin conditions
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12018043
CD73 inhibitors
granted -
US 12005080
Method for promoting proliferation of immune cells
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11858915
Polo like kinase 4 inhibitors
granted -
US 11807658
CD73 inhibitors
granted
Frequently asked questions
What is US patent 10870632?
US 10870632 (Process for producing an extract containing tetrahydrocannabinol and cannabidiol from cannabis plant material, and cannabis extracts) is held by BIONORICA ETHICS GMBH. Status: granted. Granted Dec 22, 2020. Expires Dec 17, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10870632?
BIONORICA ETHICS GMBH is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 52 pharmaceutical patents for this assignee.
When does US 10870632 expire?
Our index shows an expiration date of Dec 17, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.